表紙
市場調查報告書

止血閥的全球市場 - 至2023年的預測:附止血閥Y連接器,雙重Y連接器止血閥,單手操作止血閥

Hemostasis Valve Market by Type (Hemostasis Valve Y Connector, Double Y Connector Hemostasis Valve, One Handed), Application (Angioplasty, Angiography), End User (Hospitals), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023

出版商 MarketsandMarkets 商品編碼 765930
出版日期 內容資訊 英文 99 Pages
訂單完成後即時交付
價格
止血閥的全球市場 - 至2023年的預測:附止血閥Y連接器,雙重Y連接器止血閥,單手操作止血閥 Hemostasis Valve Market by Type (Hemostasis Valve Y Connector, Double Y Connector Hemostasis Valve, One Handed), Application (Angioplasty, Angiography), End User (Hospitals), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023
出版日期: 2019年01月03日內容資訊: 英文 99 Pages
簡介

止血閥市場將從2018年的1億3200萬美元,到2023年擴大到1億7500萬美元。市場在2018年∼2023年間,預測將以年複合成長率 (CAGR) 5.8%的速度成長。

本報告提供全球止血閥市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 止血閥:市場概要
  • 北美 - 止血閥市場:各用途
  • 止血閥市場各地區概述

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 機會

第6章 止血閥的全球市場:各類型

  • 簡介
  • 附止血閥Y連接器
  • 雙重Y連接器止血閥
  • 單手操作止血閥
  • 其他

第7章 止血閥的全球市場:各用途

  • 簡介
  • 血管造影術
  • 血管新生

第8章 止血閥的全球市場:各終端用戶

  • 簡介
  • 醫院
  • 其他

第9章 止血閥的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第10章 競爭情形

  • 概要
  • 市場排行榜分析
  • 競爭模式

第11章 企業簡介

  • BOSTON SCIENTIFIC
  • ABBOTT
  • MERIT MEDICAL SYSTEMS
  • TELEFLEX INCORPORATED
  • B. BRAUN MELSUNGEN AG
  • DEROYAL INDUSTRIES, INC.
  • Terumo Corporation
  • ARGON MEDICAL
  • FREUDENBERG MEDICAL (FREUDENBERG GROUP的子公司)
  • SCITECH

第12章 附錄

目錄
Product Code: MD 6824

"The global hemostasis valves market is projected to register a CAGR of 5.8% during the forecast period."

The market size for hemostasis valves is expected to reach 175 million by 2023 from USD 132 million in 2018, at a CAGR of 5.8%. The growth in this market is attributed to the increasing number of interventional procedures. Emerging markets will be the key growth hotspots in the hemostasis valves market; a favorable market scenario in these countries will serve to attract a number of players to focus on opportunities there.

"The hemostasis valve Y-connectors segment to dominate the market in 2018."

On the basis of type, the hemostasis valves market is segmented into hemostasis valve Y-connectors, double Y-connector hemostasis valves, one-handed hemostasis valves, and other hemostasis valves. In 2018, the hemostasis valve Y-connectors segment is expected to account for the largest share of the hemostasis valves market. The increasing number of interventional procedures worldwide is a key factor driving the growth of this segment.

"The angiography segment is estimated to grow rapidly during the forecast period."

On the basis of application, the hemostasis valves market is segmented into two segments, namely, angiography and angioplasty. During the forecast period, the angiography segment is estimated to register the highest growth rate in the overall hemostasis valves market. This growth is mainly due to the increasing number of coronary angiography procedures. With the increasing number of angiography procedures, the demand for hemostasis valves is expected to increase during procedures.

"Asia Pacific is estimated to register the highest CAGR during the forecast period."

In this report, the hemostasis valves market is segmented into four major regional segments-North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the increasing number of interventional procedures, increasing number of hospitals, and growing geriatric population.

Breakdown of Profiles of Primary Participants:

  • By Company Type: Tier 1-70% and Tier 2-30%
  • By Designation: C-level-38%, Managers - 62%
  • By Region: North America-50%, Europe-20%, Asia Pacific-30%

Key players in the hemostasis valves market include: Teleflex Incorporated (US), Boston Scientific (US), Abbott (US), B. Braun Melsungen (Germany), DeRoyal Industries, Inc. (US), Freudenberg Medical (US), Argon Medical (US), and Scitech (Brazil).

Research Coverage:

The report analyzes the hemostasis valves market by type, application, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:

This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the hemostasis valves market
  • Product Development/Innovation: Detailed insights on the product approvals, R&D activities, and product launches in the hemostasis valves market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the hemostasis valves market
  • Market Development: Detailed information about emerging markets. The report analyzes the market for various hemostasis valves across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the hemostasis valves market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. COUNTRY COVERAGE
    • 1.2.3. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY DATA
    • 2.1.1. KEY DATA FROM SECONDARY SOURCES
  • 2.2. PRIMARY DATA
    • 2.2.1. KEY DATA FROM PRIMARY SOURCES
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. HEMOSTASIS VALVES: MARKET OVERVIEW
  • 4.2. NORTH AMERICA: HEMOSTASIS VALVES MARKET, BY APPLICATION (2018)
  • 4.3. GEOGRAPHICAL SNAPSHOT OF THE HEMOSTASIS VALVES MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing number of interventional procedures
    • 5.2.2. OPPORTUNITIES
      • 5.2.2.1. Emerging economies
      • 5.2.2.2. Growth in the number of hospitals

6. HEMOSTASIS VALVES MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. HEMOSTASIS VALVE Y-CONNECTORS
    • 6.2.1. HEMOSTASIS VALVE Y-CONNECTORS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE HEMOSTASIS VALVES MARKET DURING THE FORECAST PERIOD
  • 6.3. DOUBLE Y-CONNECTOR HEMOSTASIS VALVES
    • 6.3.1. DOUBLE Y-CONNECTOR HEMOSTASIS VALVES ARE THE FASTEST-GROWING SEGMENT OF THE ONE-HANDED HEMOSTASIS VALVES MARKET
  • 6.4. ONE-HANDED HEMOSTASIS VALVES
    • 6.4.1. SELF-CLOSING MECHANISM OF ONE-HANDED HEMOSTASIS VALVES TO DRIVE ADOPTION
  • 6.5. OTHER HEMOSTASIS VALVES

7. HEMOSTASIS VALVES MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. ANGIOGRAPHY
    • 7.2.1. INCREASING NUMBER OF CORONARY ANGIOGRAPHY PROCEDURES TO DRIVE MARKET GROWTH
  • 7.3. ANGIOPLASTY
    • 7.3.1. INCREASING BURDEN OF CORONARY HEART DISEASE TO DRIVE MARKET GROWTH

8. HEMOSTASIS VALVES MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS
    • 8.2.1. ACCESS TO ADVANCED FACILITIES AND SKILLED PERSONNEL IS DRIVING PATIENT PREFERENCE FOR HOSPITAL CARE
  • 8.3. OTHER END USERS

9. HEMOSTASIS VALVES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
      • 9.2.1.1. Rising target disease incidence has aided the adoption of new technologies in the US
    • 9.2.2. CANADA
      • 9.2.2.1. Increasing number of PCI procedures
  • 9.3. EUROPE
    • 9.3.1. GERMANY
      • 9.3.1.1. Increasing number of intervention procedures
    • 9.3.2. UK
      • 9.3.2.1. Rising geriatric population
    • 9.3.3. FRANCE
      • 9.3.3.1. Rising geriatric population
    • 9.3.4. REST OF EUROPE
  • 9.4. ASIA PACIFIC
    • 9.4.1. CHINA
      • 9.4.1.1. China will account for the largest share of the APAC market
    • 9.4.2. INDIA
      • 9.4.2.1. High prevalence of target diseases will ensure demand growth in India
    • 9.4.3. JAPAN
      • 9.4.3.1. CVD mortality has decreased in the country
    • 9.4.4. REST OF ASIA PACIFIC
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET RANKING ANALYSIS, 2017
  • 10.3. COMPETITIVE SCENARIO
    • 10.3.1. ACQUISITIONS
    • 10.3.2. EXPANSIONS
    • 10.3.3. PRODUCT LAUNCHES
    • 10.3.4. COLLABORATIONS

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. BOSTON SCIENTIFIC
  • 11.2. ABBOTT
  • 11.3. MERIT MEDICAL SYSTEMS
  • 11.4. TELEFLEX INCORPORATED
  • 11.5. B. BRAUN MELSUNGEN AG
  • 11.6. DEROYAL INDUSTRIES, INC.
  • 11.7. TERUMO
  • 11.8. ARGON MEDICAL
  • 11.9. FREUDENBERG MEDICAL (A SUBSIDIARY OF FREUDENBERG GROUP)
  • 11.10. SCITECH

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS
  • 12.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 2: NORTH AMERICA: HEMOSTASIS VALVES MARKET , BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 3: EUROPE: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 4: ASIA PACIFIC: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 5: ROW: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 6: HEMOSTASIS VALVE Y-CONNECTORS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 7: DOUBLE Y-CONNECTOR HEMOSTASIS VALVES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 8: ONE-HANDED HEMOSTASIS VALVES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 9: OTHER HEMOSTASIS VALVES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 10: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 11: HEMOSTASIS VALVES MARKET FOR ANGIOGRAPHY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 12: HEMOSTASIS VALVES MARKET FOR ANGIOPLASTY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 13: NORTH AMERICA: CORONARY ANGIOPLASTY MARKET, 2016-2023 (NUMBER OF PROCEDURES)
  • TABLE 14: EUROPE: CORONARY ANGIOPLASTY MARKET, 2016-2023 (NUMBER OF PROCEDURES)
  • TABLE 15: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 16: HEMOSTASIS VALVES MARKET FOR HOSPITALS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 17: HEMOSTASIS VALVES MARKET FOR OTHER END USERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 18: HEMOSTASIS VALVES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 19: NORTH AMERICA: HEMOSTASIS VALVES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 20: NORTH AMERICA: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 21: NORTH AMERICA: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 22: NORTH AMERICA: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 23: US: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 24: US: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 25: US: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 26: CANADA: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 27: CANADA: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 28: CANADA: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 29: EUROPE: HEMOSTASIS VALVES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 30: EUROPE: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 31: EUROPE: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 32: EUROPE: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 33: GERMANY: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 34: GERMANY: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 35: GERMANY: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 36: UK: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 37: UK: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 38: UK: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 39: FRANCE: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 40: FRANCE: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 41: FRANCE: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 42: ROE: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 43: ROE: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 44: ROE: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 45: ASIA PACIFIC: HEMOSTASIS VALVES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 46: ASIA PACIFIC: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 47: ASIA PACIFIC: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 48: ASIA PACIFIC: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 49: CHINA: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 50: CHINA: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 51: CHINA: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 52: INDIA: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 53: INDIA: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 54: INDIA: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 55: JAPAN: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 56: JAPAN: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 57: JAPAN: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 58: AUSTRALIA: INCREASE IN ANGIOPLASTY PROCEDURES, 2011 TO 2016
  • TABLE 59: ROAPAC: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 60: ROAPAC: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 61: ROAPAC: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 62: ROW: HEMOSTASIS VALVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 63: ROW: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 64: ROW: HEMOSTASIS VALVES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 65: TOP FIVE COMPANIES IN THE HEMOSTASIS VALVES MARKET, 2017

LIST OF FIGURES

  • FIGURE 1: GLOBAL HEMOSTASIS VALVES MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: HEMOSTASIS VALVES MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: HEMOSTASIS VALVES MARKET: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: HEMOSTASIS VALVES MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: HEMOSTASIS VALVES MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: HEMOSTASIS VALVES MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: HEMOSTASIS VALVES MARKET, BY REGION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 11: INCREASING NUMBER OF INTERVENTIONAL PROCEDURES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 12: ANGIOGRAPHY TO DOMINATE THE NORTH AMERICAN HEMOSTASIS VALVES MARKET IN 2018
  • FIGURE 13: COUNTRIES IN ASIA PACIFIC TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 14: HEMOSTASIS VALVES MARKET: DRIVERS, & OPPORTUNITIES
  • FIGURE 15: HEMOSTASIS VALVE Y-CONNECTORS TO DOMINATE THE HEMOSTASIS VALVES MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: ANGIOGRAPHY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE HEMOSTASIS VALVES MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: HOSPITALS TO REGISTER THE HIGHEST GROWTH RATE IN THE HEMOSTASIS VALVES MARKET DURING 2018-2023
  • FIGURE 18: ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 19: NORTH AMERICA: HEMOSTASIS VALVES MARKET SNAPSHOT
  • FIGURE 20: ASIA PACIFIC: HEMOSTASIS VALVES MARKET SNAPSHOT
  • FIGURE 21: KEY DEVELOPMENTS OF MAJOR PLAYERS FROM 2015-2018
  • FIGURE 22: BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 23: ABBOTT : COMPANY SNAPSHOT
  • FIGURE 24: MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT
  • FIGURE 25: TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 26: B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • FIGURE 27: TERUMO: COMPANY SNAPSHOT
  • FIGURE 28: FREUDENBERG GROUP: COMPANY SNAPSHOT